AIDS & HIV Study suggests dolutegravir is the optimal first-line HIV medication Posted on October 20, 2020March 12, 2022 | by mymedicplus
AIDS & HIV Researchers discover how a small molecule is the key to HIV forming capsules Posted on October 20, 2020March 12, 2022 | by mymedicplus
AIDS & HIV A new treatment for AIDS by injection Posted on October 19, 2020March 12, 2022 | by mymedicplus
AIDS & HIV Patients with HIV and four-class drug resistance have high disease burden Posted on October 12, 2020 | by mymedicplus
AIDS & HIV Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study. Posted on October 6, 2020 | by mymedicplus
AIDS & HIV WHY FAITH COMMUNITIES ARE AN ORGANIC PART OF HIV/AIDS CARE Posted on March 7, 2020 | by mymedicplus
AIDS & HIV Whitman-Walker launches HIV vaccination study Posted on March 7, 2020March 31, 2021 | by mymedicplus
AIDS & HIV Instant HIV test could slow spread of disease Posted on March 7, 2020March 31, 2021 | by mymedicplus
AIDS & HIV ‘Health workers are too scared to enter’: the fight to treat HIV in a São Paulo favela Posted on March 4, 2020March 31, 2021 | by mymedicplus
AIDS & HIV Long-term survivors of HIV/AIDS reflect on what they’ve witnessed and endured Posted on February 27, 2020March 31, 2021 | by mymedicplus
AIDS & HIV PrEP is 99% effective in preventing HIV. The UA wants to raise awareness of the drug at Penn. Posted on February 25, 2020March 31, 2021 | by mymedicplus
AIDS & HIV Program aims to develop creative solutions for opioid, HIV health care Posted on February 25, 2020March 31, 2021 | by mymedicplus
AIDS & HIV Doctors look to HIV and Ebola drugs for coronavirus cure Posted on February 21, 2020March 31, 2021 | by mymedicplus
